Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial-Reference-Cited by-同舟云学术

Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial

Published:2018-10-04 Issue:1 Volume:93 Page:E1-E7
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Costa J. Ribamar¹,Abizaid Alexandre¹,Whitbourn Robert²,Serruys Patrick W.³^ORCID,Jepson Nigel⁴,Steinwender Clemens⁵,Stuteville Marrianne⁶,Ediebah Divine⁶,Sudhir Krishnankutty⁷,Bartorelli Antonio L.⁸,

Affiliation:

1. Instituto de Cardiologia Dante Pazzanese; Sao Paulo Brazil

2. St. Vincent's Hospital; Fitzroy Victoria Australia

3. Thoraxcenter Erasmus University Medical Center; Rotterdam The Netherlands

4. Prince of Wales Public; Sydney Australia

5. Allgemeines Krankenhaus Linz; Linz Austria

6. Abbott Vascular; Diegem Belgium

7. Abbott Vascular; Santa Clara

8. Centro Cardiologico Monzino, IRCCS; University of Milan; Milan Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.27715/fullpdf

Reference25 articles.

1. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: Early and midterm outcomes from the European multicentre GHOST-EU registry;Capodanno;EuroIntervention,2015

2. Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: A systematic review and meta-analysis;Lipinski;JACC Cardiovasc Interv,2016

3. 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: A patient-level, pooled meta-analysis;Stone;Lancet,2016

4. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: A meta-analysis of randomised controlled trials;Cassese;Lancet,2016

5. Very late scaffold thrombosis: Intracoronary imaging and histopathological and spectroscopic findings;Räber;J Am Coll Cardiol,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioresorbable stents: Is the game over?;International Journal of Cardiology;2022-08

2. Major adverse cardiovascular events after implantation of absorb bioresorbable scaffold: One-year clinical outcomes;Scripta Medica;2021

3. Bioresorbable Scaffolds: Current Technology and Future Perspectives;Rambam Maimonides Medical Journal;2020-04-29

4. Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation;Catheterization and Cardiovascular Interventions;2020-03-18

5. Poly ( l ‐lactic acid) bioresorbable scaffolds versus metallic drug‐eluting stents for the treatment of coronary artery disease: A meta‐analysis of 11 randomized trials;Catheterization and Cardiovascular Interventions;2019-11-15